Year-over-year, this metric declined by 102.2%, from $1.57B to -$34.40M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a 19.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$236.70M | -$9.80M | -$13.80M | -$9.20M | -$18.20M | -$10.00M | -$15.10M | -$16.90M | -$1.10B | -$23.30M | -$20.60M | -$15.80M | -$18.50M | -$696.00M | -$28.10M | $1.57B | -$990.80M | -$21.90M | $0.00 | -$34.40M |
| QoQ Change | — | +95.9% | -40.8% | +33.3% | -97.8% | +45.1% | -51.0% | -11.9% | <-999% | +97.9% | +11.6% | +23.3% | -17.1% | <-999% | +96.0% | >999% | -163.2% | +97.8% | +100.0% | — |
| YoY Change | — | — | — | — | +92.3% | -2.0% | -9.4% | -83.7% | <-999% | -133.0% | -36.4% | +6.5% | +98.3% | <-999% | -36.4% | >999% | <-999% | +96.9% | +100.0% | -102.2% |